Sources say Lilly the mystery buyer in ImClone deal
NEW YORK It appears the mystery company that beat out Bristol-Myers Squibb in the bidding war for ImClone has been revealed.
According to reports, Indianapolis-based Eli Lilly offered $70 a share for the New York biotech, which specializes in cancer drugs.
Bristol, which owns 16.6 percent of ImClone, had offered $60 a share, which it later increased to $62, but its offer drew ridicule from ImClone chairman Carl Icahn. Bristol has a partnership with ImClone to market the cancer drug Erbitux (cetuximab).
Albertsons begins $4.99 generic prescription drug program
BOISE, Idaho Albertsons today announced the launch of Albertsons Rx-tra Savings prescription discount program. The membership-based program offers 30-day supplies of more than 500 generic prescription drugs for $4.99. Albertsons pharmacies are also discontinuing the “Meet or Beat” pricing program, the company said.
Generic drugs included in the program include treatments for asthma, depression, diabetes, heart disease and other health issues.
To join the program, members can pay a one-time $10 fee at the pharmacy to cover all members of the household. To launch the program, for a limited time Albertson’s is giving away $10 Albertsons gift certificates to those who sign up.
Albertsons operates 250 units in Arizona, Arkansas, Colorado, Florida, Louisiana, New Mexico and Texas.
APhA encourages more patient-pharmacist communication
WASHINGTON The American Pharmacists Association is urging customers to get to know their pharmacists for American Pharmacists Month, APhA said Wednesday.
“Pharmacists are on the frontlines of helping patients get the most out of their medications,” APhA chief executive officer and executive vice president John Gans said.
“As our population ages, and more people become dependent on medications than ever before, pharmacists will play an increasingly prevalent role on the healthcare team and in improving medication use and advancing patient care.”
An APhA survey has shown that almost 70 percent of consumers don’t know their pharmacists’ names, so during its campaign, the organization plans to “underscore the link between knowing your pharmacist and the safe and effective use of medications” and inform consumers of some of the patient-care services that pharmacists offer.